Infusions, IntravenousFluorouracilLeucovorinAntineoplastic Combined Chemotherapy ProtocolsOrganoplatinum CompoundsCamptothecinDrug Administration ScheduleColorectal NeoplasmsTreatment OutcomeChronotherapyNeoplasm MetastasisCyclophosphamideDoxorubicinSurvival AnalysisAntimetabolites, AntineoplasticCisplatinEtoposideLevoleucovorinAdenocarcinomaEpirubicinSurvival RateDeoxycytidineDisease-Free SurvivalChemotherapy, AdjuvantMaximum Tolerated DoseLymphoma, AIDS-RelatedDose-Response Relationship, DrugCombined Modality TherapyInfusion PumpsMitomycinVincristinePrednisoneMethotrexateLymphoma, Non-HodgkinInjections, IntravenousNeutropeniaSalvage TherapyNeoplasm StagingAntibodies, Monoclonal, HumanizedStomach NeoplasmsRectal NeoplasmsAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsAntineoplastic Agents, PhytogenicPancreatic NeoplasmsRemission InductionBreast NeoplasmsNeoadjuvant TherapyDiarrheaRadiotherapy, AdjuvantPaclitaxelRadiotherapy DosageHead and Neck NeoplasmsCarboplatinHydroxyureaDisease ProgressionPrognosisAntibodies, MonoclonalAdministration, OralGranulocyte Colony-Stimulating FactorNeoplasmsFollow-Up StudiesColonic NeoplasmsQuinazolinesCarcinomaNeoplasm Recurrence, LocalPilot ProjectsLiver NeoplasmsProspective StudiesCarcinoma, Squamous CellTime FactorsRetrospective Studies